AGIOS PHARMACEUTICALS INC (AGIO) Stock Analyst Ratings
NASDAQ:AGIO - Nasdaq - US00847X1046 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 79% to AGIO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 57.8. This target is 64.11% above the current price.
AGIO was analyzed by 15 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about AGIO.
In the previous month the buy percentage consensus was at a similar level.
AGIO was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-18 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-12-10 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-12-09 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-11-01 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-11-01 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-10-16 | ScotiaBank | Initiate | Sector Outperform |
| 2024-10-10 | Raymond James | Reiterate | Outperform |
| 2024-09-27 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-09-20 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-09-19 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-02 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-06-17 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-13 | JP Morgan | Reiterate | Neutral -> Neutral |
| 2024-06-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-06-04 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-05-03 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-04-09 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-02-23 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-02-16 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-11-03 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-08-07 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-06-27 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-02-03 | Piper Sandler | Initiate | Overweight |
| 2022-12-01 | JP Morgan | Maintains | Neutral |
| 2022-11-17 | Goldman Sachs | Upgrade | Sell -> Neutral |
| 2022-08-05 | SVB Leerink | Maintains | Outperform |
| 2022-07-27 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2022-05-24 | Goldman Sachs | Maintains | Sell |
| 2022-05-17 | SVB Leerink | Maintains | Market Perform |
| 2022-03-07 | Goldman Sachs | Maintains | Sell |